Conference
ACR Convergence 2025
Chicago, IL
October 24 - 29, 2025
Booth # 1228
Visit Us at Booth 1228
Exagen is excited to participate in ACR Convergence 2025, the American College of Rheumatology’s annual meeting, taking place October 24–29 in Chicago, IL. This gathering brings together rheumatology professionals from around the globe for world-class education, groundbreaking scientific presentations, networking, and industry exhibits.
You can find Exagen at booth #1228, where we’ll highlight our latest advancements in autoimmune diagnostics. Beyond our booth, we’re excited to present 5 posters and 1 oral presentation alongside a featured presentation in the Innovation Theatre (details below).
If you’re attending ACR Convergence 2025, we’d love to connect. Visit our booth or contact us to arrange a meeting with an Exagen representative to learn more about our newest products, services, and technologies.
Sunday, October 26, 2024
10:00 AM - 5:00 PM CDT
Monday, October 27, 2024
10:00 AM - 5:00 PM CDT
Tuesday, October 28, 2024
10:00 AM - 2:30 PM CDT
Innovation Theater
AVISE CTD:
A Decade of Validation Driving Lupus Diagnostic Accuracy, Seronegative RA Biomarker Innovation, and Novel T Cell Biomarkers for Lupus
Monday, October 27, 2025
2:30 PM - 3:15 PM CDT
Theater A
Explore how a decade of rigorous validation behind AVISE® CTD is improving diagnostic confidence in lupus and accelerating biomarker innovation. We’ll highlight new findings in seronegative rheumatoid arthritis and review novel T-cell biomarkers for lupus—bringing clearer answers and more personalized disease management within reach.
Alvin F. Wells MD, PhD, FACP, FACR
Director of Rheumatology,
American Medical Group
Vasileios Kyttaris, MD, PhD, FACR
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
*This program is developed and offered by Exagen Inc. This is not an official program of the American College of Rheumatology.
Poster Presentations
Plenary II
Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis
Presenting Author: Andrea Fava
Plenary
Abstract Number 2128444
Date: Monday, October 27
Session Time: 8:00 AM – 9:30 AM
Presentation Time
8:30 AM – 8:45 AM CT
Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster I
A Novel Kidney-Specific Biomarker Panel Accurately Differentiates Lupus Nephritis from Diabetic Kidney Disease through Distinct Molecular Pathways
Presenting Author: Mike Nerenberg
Poster
Abstract Number 2128477
Sunday, October 26
Session Time: 10:30 AM – 12:30 PM CT
Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III
Specificity of Cell-bound T Cell Biomarkers (TC4d, TIgG, TIgM) in Differentiating SLE from ANA-Associated Rheumatic Diseases
Presenting Author: Vasileios Kyttaris
Poster
Abstract Number 2128433
Tuesday, October 28
Session Time: 10:30 AM – 12:30 PM CT
Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III
Kidney-Specific Four-Protein Index Outperforms Conventional Measures for Detecting Early Kidney Damage in Lupus Nephritis and Diabetic Kidney Disease
Presenting Author: Mike Nerenberg
Poster
Abstract Number 2128438
Tuesday, October 28
Session Time: 10:30 AM – 12:30 PM CT
Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III
The Clinical Utility of a Multianalyte Lupus Risk Score Incorporating Cell-bound Complement Activation Products: A Systematic Evaluation
Presenting Author: Vasileios Kyttaris
Poster
Abstract Number 2128444
Tuesday, October 28
Session Time: 10:30 AM – 12:30 PM CT